8 recruiting. 8 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Recruiting 8 |
| Phase 3 | 2 | Recruiting 2 |
Follow Vitiligo: new trials by email Literature Review of Vitiligo trials Research Report on Vitiligo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of D-2570 in Subjects With Non-Segmental Vitiligo D-2570 Dose 1, D-2570 Dose 2, Placebo - Vitiligo, Non-Segmental Vitiligo (NSV) | Phase 2 | Recruiting | InventisBio Co., Ltd | 160 | 2026-06-11 | 2026-07-15 |
| A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo LY4005130, Placebo - Vitiligo, Non-Segmental Vitiligo (NSV) | Phase 2 | Recruiting | Eli Lilly and Company | 66 | 2026-04-14 | 2026-10-08 |
| Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo LITFULO, LITFULO and UVB - Vitiligo | Phase 2 | Recruiting | Centre Hospitalier Universitaire de Nice | 56 | 2026-03-12 | 2026-05-20 |
| A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo GIA632, Placebo - Non-segmental Vitiligo | Phase 2 | Recruiting | Novartis Pharmaceuticals | 210 | 2026-03-09 | 2026-10-13 |
| Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo Melanotan II (MT-II), Placebo, Narrowband UV-B (NB-UVB) phototherapy - NonSegmental Vitiligo, Nonsegmental Vitiligo (Stable) | Phase 2 | Recruiting | Hudson Biotech | 60 | 2026-02-02 | 2026-02-27 |
| Gingival Hyperpigmentation Treatment Vitamin c and glutathione, Surgical depigmentation - Gingival Pigmentation, Depigmentation | Phase 2 | Recruiting | Cairo University | 30 | 2025-08-01 | 2026-05-19 |
| Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical Tacrolimus Ruxolitinib Cream 1.5%, Aqueous cream - Vitiligo | Phase 2 / Phase 3 | Recruiting | Hospital Authority, Hong Kong | 20 | 2024-11-29 | 2024-12-05 |
| Vitiligo, New Treatment and Serum s100B Baricitinib, oral mini pulse, Narrow Band UVB Treatment - Vitiligo, Generalized | Phase 2 / Phase 3 | Recruiting | South Valley University | 50 | 2024-10-02 | 2025-01-10 |
Hypopigmentation (8) · Skin Diseases (8) · Skin and Connective Tissue Diseases (8) · Pigmentation Disorders (7) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Ascorbic Acid (1) · Glutathione (1) · Phototherapy (1) · baricitinib (1) · melanotan-II (1)
Cairo University (1) · Centre Hospitalier Universitaire de Nice (1) · Eli Lilly and Company (1) · Hospital Authority, Hong Kong (1) · Hudson Biotech (1) · InventisBio Co., Ltd (1) · Novartis Pharmaceuticals (1) · South Valley University (1)
China (4) · Canada (2) · Egypt (2) · France (2) · United States (2) · Argentina (1) · Australia (1) · Belgium (1) · Germany (1) · Hong Kong (1) · India (1) · Italy (1) · Japan (1) · Netherlands (1) · Poland (1)
Nourhan A Abdullah, Phd (1) · YM Lau (1)
2025 (3)